3 Biopharma Execs On Bringing A Startup Out Of Academia
Source: Life Science Leader
In this executive virtual roundtable (EVR) segment, Steffen Mueller, Ph.D., cofounder and CSO, Codagenix; Rahul Aras, Ph.D., CEO of Iterion Therapeutics; and Prem Premsrirut, M.D., Ph.D., CEO, Mirimus, provide perspective and advice on bringing a startup out of an academic setting.
This website uses cookies to ensure you get the best experience on our website. Learn more